SCHEMBL574413

SCHEMBL574413

CCCC(C)(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716231 1.00
SCHEMBL160132 1.00
Hydrochloric Acid SCHEMBL27850578 0.97 GGT1 (0.56)
Hydrochloric Acid SCHEMBL1807627 0.97 GGT1 (0.56)
SCHEMBL3419888 0.87 ARG1 (0.52)
SCHEMBL8687592 0.86 GGT1 (0.65)
SCHEMBL18124758 0.85 ARG1 (0.59)
SCHEMBL186714 0.85 ARG1 (0.59)
SCHEMBL162337 0.85 ARG1 (0.59)
Hydrochloric Acid SCHEMBL18109448 0.83 ARG1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113651946-B Epoxy resin curing agent and preparation method and application thereof 万华化学集团股份有限公司(CN) 2023-01-13 CN claimed
CN-114729006-A Cyclic peptide compounds having Kras inhibitory activity 中外制药株式会社 2022-07-08 CN claimed
CN-113651946-A Epoxy resin curing agent and preparation method and application thereof 万华化学集团股份有限公司 2021-11-16 CN claimed
US-20170106344-A1 CONDITIONED SURFACES FOR IN SITU MOLECULAR ARRAY SYNTHESIS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-04-20 US claimed
JP-4511835-B2 2010-07-28 JP claimed
US-20040259930-A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof MALESCI INSTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2004-12-23 US claimed
EP-1442050-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) 2004-08-04 EP claimed
WO-2003037916-A2 LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. (IT) 2003-05-08 WO claimed
EP-0458307-B1 Method for stabilizing taste-modifier KURIHARA YOSHIE (JP) 1995-10-18 EP claimed
EP-0458307-A1 Method for stabilizing taste-modifier Kurihara, Yoshie (JP) 1991-11-27 EP claimed
US-20260116927-A1 Synthesis of GLP-1R/GIPR Agonists and Precursors Thereof CARMOT THERAPEUTICS INC. (US) 2026-04-30 US disclosed
EP-4731645-A1 SYNTHESIS OF GLP-1R/GIPR AGONISTS AND PRECURSORS THEREOF Carmot Therapeutics Inc. (US) 2026-04-29 EP disclosed
US-20260035406-A1 SYNTHESIS OF GLP-1R/GIPR AGONISTS CARMOT THERAPEUTICS INC. (US) 2026-02-05 US disclosed
WO-2024264014-A1 SYNTHESIS OF GLP-1R/GIPR AGONISTS AND PRECURSORS THEREOF CARMOT THERAPEUTICS INC. (US) 2024-12-26 WO disclosed
US-20240182532-A1 MICROPEPTIDES AND USES THEREOF FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) 2024-06-06 US disclosed
US-4353828-A Preparation of fluorinated methyl aminoalkanoic acids and novel process intermediates MERRELL TORAUDE ET COMPAGNIE (FR) 1982-10-12 US disclosed
EP-0025370-A2 Preparation of fluorinated methylaminoalkanoic acids, process intermediates and their preparation MERRELL TORAUDE ET COMPAGNIE (FR) 1981-03-18 EP disclosed
US-4217238-A BASIC SALT, SCRUBBING EXXON RESEARCH & ENGINEERING CO. (US) 1980-08-12 US disclosed
US-RE30170-E Hydrolyzable polymers of amino acid and hydroxy acids SUTURES, INC. (US) 1979-12-18 US disclosed
US-4094957-A CARBON DIOXIDE EXXON RESEARCH & ENGINEERING CO. (US) 1978-06-13 US disclosed